UNITED STATES OF AMERICA —Stockholders of Integer Holdings Corporation have given final shareholder approval for the company’s pending merger with Armstrong Parent, an entity affiliated with investment manager KKR. At a special meeting of stockholders, the merger agreement received support from approximately 99.95% of votes cast, representing roughly 76.66% of total outstanding common stock. Investors also voted in favor of a separate non-binding advisory measure concerning executive transaction compensation tied to the buyout deal, which was originally executed in August 2026.
The successful shareholder vote satisfies a central prerequisite for completing the buyout, which remains on track to close before the end of 2026 pending customary regulatory clearances and final closing conditions. Headquartered in Plano, Texas, Integer Holdings operates as a medical device contract development and manufacturing organization, maintaining specialized brands including Greatbatch Medical and Lake Region Medical to supply components and engineering solutions for cardio, vascular, neuromodulation, and cardiac rhythm management markets globally.
The transition of a major contract development and manufacturing provider into private equity hands reflects broader market consolidation across healthcare technology and medical component manufacturing. For medical device original equipment manufacturers, the acquisition underscores a growing reliance on large-scale, highly integrated outsourcing partners capable of sustaining substantial capital investment in complex research, regulatory compliance, and high-precision manufacturing processes.
For institutional investors and market participants, the transaction highlights continued private equity appetite for scalable healthcare infrastructure and medtech supply chain assets. Taking Integer private removes public market equity exposure for the entity while providing the company with private capital backing to expand its specialized engineering capabilities and global operational footprint across the medical device value chain.
